|
1
|
Bushby K, Finkel R, Birnkrant DJ, Case LE,
Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, et
al: Diagnosis and management of Duchenne muscular dystrophy, part
1: Diagnosis, and pharmacological and psychosocial management.
Lancet Neurol. 9:77–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ryder S, Leadley RM, Armstrong N, Westwood
M, de Kock S, Butt T, Jain M and Kleijnen J: The burden,
epidemiology, costs and treatment for Duchenne muscular dystrophy:
An evidence review. Orphanet J Rare Dis. 12:792017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Magri F, Govoni A, D'Angelo MG, Del Bo R,
Ghezzi S, Sandra G, Turconi AC, Sciacco M, Ciscato P, Bordoni A, et
al: Genotype and phenotype characterization in a large
dystrophinopathic cohort with extended follow-up. J Neurol.
258:1610–1623. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lopez-Hernandez LB, Gomez-Diaz B,
Luna-Angulo AB, Anaya-Segura M, Bunyan DJ, Zuniga-Guzman C,
Escobar-Cedillo RE, Roque-Ramirez B, Ruano-Calderon LA,
Rangel-Villalobos H, et al: Comparison of mutation profiles in the
Duchenne muscular dystrophy gene among populations: Implications
for potential molecular therapies. Int J Mol Sci. 16:5334–5346.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taylor PJ, Maroulis S, Mullan GL, Pedersen
RL, Baumli A, Elakis G, Piras S, Walsh C, Prosper-Gutierrez B, De
La Puente-Alonso F, et al: Measurement of the clinical utility of a
combined mutation detection protocol in carriers of Duchenne and
Becker muscular dystrophy. J Med Genet. 44:368–372. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang P, Du CW, Kwan M, Liang SX and Zhang
GJ: The impact of p53 in predicting clinical outcome of breast
cancer patients with visceral metastasis. Sci Rep. 3:22462013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Juan-Mateu J, Rodriguez MJ, Nascimento A,
Jiménez-Mallebrera C, González-Quereda L, Rivas E, Paradas C,
Madruga M, Sanchez-Ayaso P, Jou C, et al: Prognostic value of
X-chromosome inactivation in symptomatic female carriers of
dystrophinopathy. Orphanet J Rare Dis. 7:822012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arikawa E, Hoffman EP, Kaido M, Nonaka I,
Sugita H and Arahata K: The frequency of patients with dystrophin
abnormalities in a limb-girdle patient population. Neurology.
41:1491–1496. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seemann N, Campbell C, Hammond R and
Prasad C: 9 year old girl with progressive weakness. Brain Pathol.
20:255–256. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mercier S, Toutain A, Toussaint A, Raynaud
M, de Barace C, Marcorelles P, Pasquier L, Blayau M, Espil C,
Parent P, et al: Genetic and clinical specificity of 26 symptomatic
carriers for dystrophinopathies at pediatric age. Eur J Hum Genet.
21:855–863. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dabby R, Sadeh M, Herman O, Berger E,
Watemberg N, Hayek S, Jossiphov J and Nevo Y: Asymptomatic or
minimally symptomatic hyperCKemia: Histopathologic correlates. Isr
Med Assoc J. 8:110–113. 2006.PubMed/NCBI
|
|
12
|
Wang Q, Yang X, Yan Y, Song N, Lin C and
Jin C: Duchenne or Becker muscular dystrophy: A clinical, genetic
and immunohistochemical study in China. Neurol India. 59:797–802.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luce LN, Ottaviani D, Ferrer M, Szijan I,
Cotignola J and Giliberto F: Molecular diagnosis of
dystrophinopathies using a multi-technique analysis algorithm.
Muscle Nerve. 49:249–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Voermans NC, de Visser M, Wokke JH and
Brusse E: Increased CK activity in serum without symptoms: Further
investigations often unnecessary. Ned Tijdschr Geneeskd.
157:A63152013.(In Dutch). PubMed/NCBI
|
|
15
|
Hoogerwaard EM, Ginjaar IB, Bakker E and
de Visser M: Dystrophin analysis in carriers of Duchenne and Becker
muscular dystrophy. Neurology. 65:1984–1986. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Soltanzadeh P, Friez MJ, Dunn D, von
Niederhausern A, Gurvich OL, Swoboda KJ, Sampson JB, Pestronk A,
Connolly AM, Florence JM, et al: Clinical and genetic
characterization of manifesting carriers of DMD mutations.
Neuromuscul Disord. 20:499–504. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SH, Lee JH, Lee KA and Choi YC:
Clinical and genetic characterization of female dystrophinopathy. J
Clin Neurol. 11:248–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhong J, Xu T, Chen G, Liao H, Zhang J and
Lan D: Genetic analysis of the dystrophin gene in children with
Duchenne and Becker muscular dystrophies. Muscle Nerve. 56:117–121.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mukherjee M, Chaturvedi LS, Srivastava S,
Mittal RD and Mittal B: De novo mutations in sporadic deletional
Duchenne muscular dystrophy (DMD) cases. Exp Mol Med. 35:113–117.
2003. View Article : Google Scholar : PubMed/NCBI
|
